# Filing Detail

Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-23-020945
Filing Date
2023-04-27
Accepted
2023-04-27 16:17:06
Documents
21

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | DEF 14A | ny20007126x1_def14a.htm iXBRL | DEF 14A | 1985213
6 |  | logo_biocryst2a.jpg | GRAPHIC | 22227
7 |  | ny20007126x1-pc_1.jpg | GRAPHIC | 817285
8 |  | ny20007126x1-pc_2.jpg | GRAPHIC | 496396
9 |  | ny20007126x1_barchart01.jpg | GRAPHIC | 159876
10 |  | ny20007126x1_barchart02.jpg | GRAPHIC | 139969
11 |  | ny20007126x1_barchart03.jpg | GRAPHIC | 151400
12 |  | ny20007126x1_table01.jpg | GRAPHIC | 345705
| Complete submission text file | 0001140361-23-020945.txt |  | 8102125

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
2 | XBRL TAXONOMY EXTENSION SCHEMA | bcrx-20230613.xsd | EX-101.SCH | 5133
3 | XBRL TAXONOMY EXTENSION DEFINITION LINKBASE | bcrx-20230613_def.xml | EX-101.DEF | 5528
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | bcrx-20230613_lab.xml | EX-101.LAB | 18048
5 | XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE | bcrx-20230613_pre.xml | EX-101.PRE | 26795
15 | EXTRACTED XBRL INSTANCE DOCUMENT | ny20007126x1_def14a_htm.xml | XML | 189387

Mailing Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703
Business Address 4505 EMPEROR BOULEVARD SUITE 200 DURHAM NC 27703 919-859-1302
BIOCRYST PHARMACEUTICALS INC (Filer) CIK: 0000882796 (see all company filings)

EIN.: 621413174 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 000-23186 | Film No.: 23857190
SIC: 2836 Biological Products, (No Diagnostic Substances)